US 8039585
Therapeutic administration of the scrambled anti-angiogenic peptide C16Y
granted A61KA61K38/08A61K38/10
Quick answer
US patent 8039585 (Therapeutic administration of the scrambled anti-angiogenic peptide C16Y) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/08, A61K38/10, A61P, A61P27/02